MATTHEW YOUNG: Open Payments
NPI 1821060062 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,980 in 88 payments from 25 companies in 2025. Trend: 2023 $64,786 · 2024 $2,028 · 2025 $1,980
Food & beverage: $1,980
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $245 |
| Amgen Inc. | 12 | $229 |
| AstraZeneca Pharmaceuticals LP | 7 | $222 |
| Lundbeck LLC | 10 | $200 |
| Axsome Therapeutics, Inc. | 6 | $153 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| HEARTFLOW, INC. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Novo Nordisk Inc | 4 | $63 |
Products named: REXULTI, KISUNLA, AIRSUPRA, REPATHA, OTEZLA, FFRct, Auvelity, CAPLYTA.
Industry payments across CO — which companies pay providers there.
